1
![Enumeral Biomedical]()
![Enumeral Biomedical]()
![Enumeral Biomedical]()
Enumeral Biomedical
Leadership team
Arthur H. Tinkelenberg (Founder)
John J. Rydzewski (Founder)
Products/ Services
Biotechnology, Nanotechnology, Therapeutics
Number of Employees
0 - 50
Headquarters
New York, New York, United States
Established
2009
Company Registration
SEC CIK number: 0001561551
Traded as
OTCQB:ENUM
URL
Overview
Location
Summary
Enumeral Biomedical provides breakthrough immuno-oncology research and development services to biopharmaceutical and academic organizations.
History
Enumeral Biomedical, Inc. was founded in 2010 and has since developed an antibody-based platform technology for studying immune cell subsets in their natural, intact states. The company's technology has the potential to accelerate drug discovery research efforts of both its industrial and academic partners.
Mission
Enumeral Biomedical is committed to delivering cutting-edge drug discovery services that enable our partners to elucidate the mechanisms of the immune system and to advance innovative products in immunology.
Vision
Enumeral Biomedical's vision is to lead the field of immuno-oncology research and to develop a new paradigm in drug discovery that will lead to a better understanding of the immune system and to a pipeline of drugs capable of treating serious immune-related diseases.
Key Team
Arthur H. Tinkelenberg (Founder)
John J. Rydzewski (Founder)
Recognition and Awards
Enumeral Biomedical has been recognized by the Massachusetts Technology Collaborative as well as the US Department of Defense with awards for its platform technology and its drug discovery capabilities.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Arthur H. Tinkelenberg (Founder)
John J. Rydzewski (Founder)
Products/ Services
Biotechnology, Nanotechnology, Therapeutics
Number of Employees
0 - 50
Headquarters
New York, New York, United States
Established
2009
Company Registration
SEC CIK number: 0001561551
Traded as
OTCQB:ENUM
URL